American Century Companies
CERE

American Century Companies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

American Century Companies’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-413,203
Closed -$17.5M – 2974
2023
Q4 		$17.5M Buy
413,203
+105,460
+34% +$3.03M 0.01% 922
2023
Q3 		$6.72M Sell
307,743
-1,504
-0.5% -$37.6K 0.01% 1225
2023
Q2 		$9.83M Buy
309,247
+55,246
+22% +$1.7M 0.01% 1057
2023
Q1 		$6.18M Buy
254,001
+2,677
+1% +$78.6K ﹤0.01% 1184
2022
Q4 		$7.93M Buy
+251,324
New +$7.09M 0.01% 1056

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

American Century Companies's CERE Position: Q1 2024 in Review

American Century Companies sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q1 2024, closing a stake of 413,203 shares — an estimated $17.5M sold.

American Century Companies first reported a position in CERE in Q4 2022 and held it in 5 quarters. The position peaked at $17.5M in Q4 2023. 210 funds tracked by Wall St. Rank hold CERE as of Q1 2024.

  • American Century Companies reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 413,203 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q1 2024, an estimated $17.5M.
  • American Century Companies first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • American Century Companies's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $17.5M in Q4 2023.
  • 210 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.